Polyrizon files U.S. patent for innovative Hydrogel Nasal technologies.

Polyrizon Ltd, a biotech innovator specializing in intranasal hydrogel technologies, has reached a pivotal milestone with the publication of its national phase patent application by the United States Patent and Trademark Office (USPTO). This patent application encompasses the company’s groundbreaking Capture and Contain (C&C) and Trap and Target (T&T) platforms. These core technologies exemplify Polyrizon’s mission to revolutionize nasal-based protection and drug delivery systems, addressing urgent medical needs for both preventive and therapeutic applications. With this development, Polyrizon strengthens its intellectual property portfolio, paving the way for commercialization and collaboration opportunities.

The Capture and Contain (C&C) platform is a state-of-the-art nasal blocker technology that utilizes a proprietary 3D polymeric network to adhere effectively to the nasal mucosa. This advanced design creates a physical barrier capable of capturing and containing airborne biological threats, including allergens, viruses, and molds. By preventing these harmful agents from penetrating the nasal cavity, the C&C technology offers a proactive and effective solution for safeguarding individuals against environmental and pathogenic risks. The innovation positions Polyrizon at the forefront of non-invasive protective technologies with potential applications in both personal health and public safety.

Complementing C&C, Polyrizon’s Trap and Target (T&T) platform delivers a transformative approach to nasal drug delivery. Engineered to prolong residence time and ensure close interaction with mucosal tissues, T&T optimizes the delivery and efficacy of therapeutic agents. The platform’s customizable nature allows it to cater to a wide range of molecules, making it adaptable for various medical applications, from treating chronic conditions to combating infectious diseases. This innovation underscores Polyrizon’s dedication to advancing drug delivery systems that enhance patient outcomes, offering healthcare providers new tools for precision medicine and improving the standard of care across diverse treatment areas.